Global Stem Cell Banking Market to Reach US$11.3 Billion by the Year 2027

Abstract: Global Stem Cell Banking Market to Reach US$11. 3 Billion by the Year 2027. Amid the COVID-19 crisis, the global market for Stem Cell Banking estimated at US$7.

New York, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Stem Cell Banking Industry" - https://www.reportlinker.com/p05799719/?utm_source=GNW
1 Billion in the year 2020, is projected to reach a revised size of US$11.3 Billion by 2027, growing at a CAGR of 6.8% over the analysis period 2020-2027.Placental and Cord Blood Stem Cells, one of the segments analyzed in the report, is projected to grow at a 7.4% CAGR to reach US$7.3 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Adipose Tissue-Derived Stem Cells (ADSCS) segment is readjusted to a revised 6.3% CAGR for the next 7-year period. This segment currently accounts for a 6.6% share of the global Stem Cell Banking market.

The U.S. Accounts for Over 29.5% of Global Market Size in 2020, While China is Forecast to Grow at a 6.4% CAGR for the Period of 2020-2027

The Stem Cell Banking market in the U.S. is estimated at US$2.1 Billion in the year 2020. The country currently accounts for a 29.55% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$2 Billion in the year 2027 trailing a CAGR of 6.4% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.4% and 5.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.5% CAGR while Rest of European market (as defined in the study) will reach US$2 Billion by the year 2027.

Bone Marrow-Derived Stem Cells (BMSCS) Segment Corners a 10.3% Share in 2020

In the global Bone Marrow-Derived Stem Cells (BMSCS) segment, USA, Canada, Japan, China and Europe will drive the 5.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$592.8 Million in the year 2020 will reach a projected size of US$858.7 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.3 Billion by the year 2027.

Select Competitors (Total 78 Featured)

• Cord Blood Registry

• CordLife Group Ltd.

• Cryo-Cell International, Inc.

• Cryo-Save AG

• Global Cord Blood Corporation

• LifeCell International Pvt., Ltd.

• Smart Cells International Ltd.

• StemCyte Inc.

• ViaCord

• Vita 34 AG

Read the full report: https://www.reportlinker.com/p05799719/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Stem Cells, Application Areas, and the Different Types - A Prelude
Applications of Stem Cells
Types of Stem Cells
Cord Blood
Umbilical Cord Tissue
Bone Marrow Stem Cells
Adipose-Derived Stem Cells (ADSCs)
Number of Clinical Trials Using Adipose Stem Cells: 2007-2018
Number of Adipose Stem Cell Trials by Phase: 2007 to 2018
Human Embryo-Derived Stem Cells (HESCS)
Global Stem Cell Banking Market Poised for a Rapid Growth
Developed Regions Lead, Emerging Economies to Spearhead Future
Growth
List of Family Cord Blood Banks in the US
Placental and Cord Blood Banks Dominate the Cord Blood Banking
Market
Global Number of Annual Newborns and Private Cord Blood Banks
Global Select Leading Cord Blood Banks Based on Inventory
A Peek into China?s Cord Blood Banking Industry
Evolving Landscape of Cord Blood Banking Industry
Placental Stem Cells and Potential Clinical Applications
EXHIBIT 1: Global Cord Blood Banking Market Share Breakdown (%)
by Bank Type: 2019
EXHIBIT 2: US Cord Blood Banking Market by Bank Type (in %) for
2019
Changing Business Models for Stem Cell Banking

2. FOCUS ON SELECT PLAYERS
Cord Blood Registry (CBR) Systems, Inc. (USA)
Cordlife Group Limited (Singapore)
Cryo Stemcell Private Limited (India)
Cryo-Cell International, Inc. (USA)
Cryoviva Biotech Private Limited (India)
Global Cord Blood Corporation (China)
LifeCell International Pvt. Ltd (India)
Smart Cells International Ltd. (UK)
StemCyte (USA)
Takara Bio Europe AB (Europe)
ViaCord (US)
Vita34 AG (Germany)

3. MARKET TRENDS & DRIVERS
Increasing Investments in Stem Cell-Based Research Widen
Prospects for Stem Cell Banking Market
EXHIBIT 3: Stem Cell Research Funding in the US (in US$
Million) for the Years 2011 through 2017
Stem Cell Research Policies Impact Funding Volumes
Adult Stem Cell Research Gains Traction, Accelerating Research
Funding
Adult Stem Cells Vs. Embryonic Stem Cells: A Comparison
Embryonic Stem Cell Research Bogged Down by Ethical Issues &
Technical Hurdles
Induced Pluripotent Stem Cell (iPSC) Research: The Latest Vertical
Sustained Emphasis on Mesenchymal Stem Cell Research
Emergence of Advanced Technologies for Stem Cell Preservation,
Storage and Processing Augurs Well for Market Growth
Growing Incidence of Major Diseases to Boost the Demand for
Stem Cells, Driving Stem Cell Banking
EXHIBIT 4: Worldwide Incidence of Cancer (2012, 2018 & 2040):
Number of New Cases Diagnosed
Table 8: World Cancer Incidence by Cancer Type (2018): Number
of New Cancer Cases Reported (in Thousands) for Breast, Cervix
uteri, Colorectum, Liver, Lung, Oesophagus, Prostate, Stomach
and Others

Table 9: Fatalities by Heart Conditions - Estimated Percentage
Breakdown for Cardiovascular Disease, Ischemic Heart Disease,
Stroke, and Others

Table 10: Global Annual Medical Cost of CVD in US$ Billion
(2010-2030)
Ageing Demographics to Drive Demand for Stem Cell Banking
Global Aging Population Statistics - Opportunity Indicators
Table 3: Elderly Population (60+ Years) as a Percentage of
Total Population (2017 & 2050)

Table 4: Global Aging Population (2017 & 2050): Population of
60+ Individuals in ?000s and as a Percentage of Total
Population

Table 5: Life Expectancy for Select Countries in Number of
Years: 2018
Bone Marrow Stem Cells Market on a Rapid Growth Path, Spurring
the Need for Stem Cell Banking
Development of Regenerative Medicine Accelerates Demand for
Mesenchymal Stem Cell Banking
Table 2: Global Regenerative Medicines Market by Category
(2019): Percentage Breakdown for Biomaterials, Stem Cell
Therapies and Tissue Engineering
Rise in Volume of Orthopedic Procedures Boosts Prospects for
Stem Cell Banking
Table 1: Global Orthopedic Surgical Procedure Volume
(2010-2020) (in Million)
Increasing Demand for Stem Cell Based Bone Grafts: Promising
Growth Ahead for Stem Cell Banking
Rise in the Number of Hematopoietic Stem Cell Transplantation
Procedures Propels Market Expansion
Hematopoietic Stem Cell Storage
Dental Mesenchymal Stem Cells: An Evolving Niche
Therapeutic Potential of Dental Pulp Stem Cells (DPSCs) in
Various Diseases
High Operational Costs of Stem Cell Banking - A Key Market
Restraint

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Stem Cell Banking
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 2: World 7-Year Perspective for Stem Cell Banking by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2020 & 2027

Table 3: World Current & Future Analysis for Placental and Cord
Blood Stem Cells by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 4: World 7-Year Perspective for Placental and Cord Blood
Stem Cells by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2020 & 2027

Table 5: World Current & Future Analysis for Adipose
Tissue-Derived Stem Cells (ADSCS) by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 6: World 7-Year Perspective for Adipose Tissue-Derived
Stem Cells (ADSCS) by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2020 & 2027

Table 7: World Current & Future Analysis for Bone
Marrow-Derived Stem Cells (BMSCS) by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 8: World 7-Year Perspective for Bone Marrow-Derived Stem
Cells (BMSCS) by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2020 & 2027

Table 9: World Current & Future Analysis for Human
Embryo-Derived Stem Cells (HESCS) by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 10: World 7-Year Perspective for Human Embryo-Derived
Stem Cells (HESCS) by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2020 & 2027

Table 11: World Current & Future Analysis for Dental
Pulp-Derived Stem Cells (DPSCS) by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 12: World 7-Year Perspective for Dental Pulp-Derived Stem
Cells (DPSCS) by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2020 & 2027

Table 13: World Current & Future Analysis for Other Stem Cell
Sources by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 14: World 7-Year Perspective for Other Stem Cell Sources
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

Table 15: World Current & Future Analysis for Sample
Preservation and Storage by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 16: World 7-Year Perspective for Sample Preservation and
Storage by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2020 & 2027

Table 17: World Current & Future Analysis for Sample Analysis
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 18: World 7-Year Perspective for Sample Analysis by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

Table 19: World Current & Future Analysis for Sample Processing
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 20: World 7-Year Perspective for Sample Processing by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

Table 21: World Current & Future Analysis for Sample Collection
and Transportation by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 22: World 7-Year Perspective for Sample Collection and
Transportation by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2020 & 2027

Table 23: World Current & Future Analysis for Personalized
Banking Applications by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 24: World 7-Year Perspective for Personalized Banking
Applications by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2020 & 2027

Table 25: World Current & Future Analysis for Research
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 26: World 7-Year Perspective for Research Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

Table 27: World Current & Future Analysis for Clinical
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 28: World 7-Year Perspective for Clinical Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 29: USA Current & Future Analysis for Stem Cell Banking
by Source - Placental and Cord Blood Stem Cells, Adipose
Tissue-Derived Stem Cells (ADSCS), Bone Marrow-Derived Stem
Cells (BMSCS), Human Embryo-Derived Stem Cells (HESCS), Dental
Pulp-Derived Stem Cells (DPSCS) and Other Stem Cell Sources -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 30: USA 7-Year Perspective for Stem Cell Banking by
Source - Percentage Breakdown of Value Sales for Placental and
Cord Blood Stem Cells, Adipose Tissue-Derived Stem Cells
(ADSCS), Bone Marrow-Derived Stem Cells (BMSCS), Human
Embryo-Derived Stem Cells (HESCS), Dental Pulp-Derived Stem
Cells (DPSCS) and Other Stem Cell Sources for the Years 2020 &
2027

Table 31: USA Current & Future Analysis for Stem Cell Banking
by Service Type - Sample Preservation and Storage, Sample
Analysis, Sample Processing and Sample Collection and
Transportation - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 32: USA 7-Year Perspective for Stem Cell Banking by
Service Type - Percentage Breakdown of Value Sales for Sample
Preservation and Storage, Sample Analysis, Sample Processing
and Sample Collection and Transportation for the Years 2020 &
2027

Table 33: USA Current & Future Analysis for Stem Cell Banking
by Application - Personalized Banking Applications , Research
Applications and Clinical Applications - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 34: USA 7-Year Perspective for Stem Cell Banking by
Application - Percentage Breakdown of Value Sales for
Personalized Banking Applications , Research Applications and
Clinical Applications for the Years 2020 & 2027

CANADA
Table 35: Canada Current & Future Analysis for Stem Cell
Banking by Source - Placental and Cord Blood Stem Cells,
Adipose Tissue-Derived Stem Cells (ADSCS), Bone Marrow-Derived
Stem Cells (BMSCS), Human Embryo-Derived Stem Cells (HESCS),
Dental Pulp-Derived Stem Cells (DPSCS) and Other Stem Cell
Sources - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 36: Canada 7-Year Perspective for Stem Cell Banking by
Source - Percentage Breakdown of Value Sales for Placental and
Cord Blood Stem Cells, Adipose Tissue-Derived Stem Cells
(ADSCS), Bone Marrow-Derived Stem Cells (BMSCS), Human
Embryo-Derived Stem Cells (HESCS), Dental Pulp-Derived Stem
Cells (DPSCS) and Other Stem Cell Sources for the Years 2020 &
2027

Table 37: Canada Current & Future Analysis for Stem Cell
Banking by Service Type - Sample Preservation and Storage,
Sample Analysis, Sample Processing and Sample Collection and
Transportation - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 38: Canada 7-Year Perspective for Stem Cell Banking by
Service Type - Percentage Breakdown of Value Sales for Sample
Preservation and Storage, Sample Analysis, Sample Processing
and Sample Collection and Transportation for the Years 2020 &
2027

Table 39: Canada Current & Future Analysis for Stem Cell
Banking by Application - Personalized Banking Applications ,
Research Applications and Clinical Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 40: Canada 7-Year Perspective for Stem Cell Banking by
Application - Percentage Breakdown of Value Sales for
Personalized Banking Applications , Research Applications and
Clinical Applications for the Years 2020 & 2027

JAPAN
Table 41: Japan Current & Future Analysis for Stem Cell Banking
by Source - Placental and Cord Blood Stem Cells, Adipose
Tissue-Derived Stem Cells (ADSCS), Bone Marrow-Derived Stem
Cells (BMSCS), Human Embryo-Derived Stem Cells (HESCS), Dental
Pulp-Derived Stem Cells (DPSCS) and Other Stem Cell Sources -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 42: Japan 7-Year Perspective for Stem Cell Banking by
Source - Percentage Breakdown of Value Sales for Placental and
Cord Blood Stem Cells, Adipose Tissue-Derived Stem Cells
(ADSCS), Bone Marrow-Derived Stem Cells (BMSCS), Human
Embryo-Derived Stem Cells (HESCS), Dental Pulp-Derived Stem
Cells (DPSCS) and Other Stem Cell Sources for the Years 2020 &
2027

Table 43: Japan Current & Future Analysis for Stem Cell Banking
by Service Type - Sample Preservation and Storage, Sample
Analysis, Sample Processing and Sample Collection and
Transportation - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 44: Japan 7-Year Perspective for Stem Cell Banking by
Service Type - Percentage Breakdown of Value Sales for Sample
Preservation and Storage, Sample Analysis, Sample Processing
and Sample Collection and Transportation for the Years 2020 &
2027

Table 45: Japan Current & Future Analysis for Stem Cell Banking
by Application - Personalized Banking Applications , Research
Applications and Clinical Applications - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 46: Japan 7-Year Perspective for Stem Cell Banking by
Application - Percentage Breakdown of Value Sales for
Personalized Banking Applications , Research Applications and
Clinical Applications for the Years 2020 & 2027

CHINA
Table 47: China Current & Future Analysis for Stem Cell Banking
by Source - Placental and Cord Blood Stem Cells, Adipose
Tissue-Derived Stem Cells (ADSCS), Bone Marrow-Derived Stem
Cells (BMSCS), Human Embryo-Derived Stem Cells (HESCS), Dental
Pulp-Derived Stem Cells (DPSCS) and Other Stem Cell Sources -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 48: China 7-Year Perspective for Stem Cell Banking by
Source - Percentage Breakdown of Value Sales for Placental and
Cord Blood Stem Cells, Adipose Tissue-Derived Stem Cells
(ADSCS), Bone Marrow-Derived Stem Cells (BMSCS), Human
Embryo-Derived Stem Cells (HESCS), Dental Pulp-Derived Stem
Cells (DPSCS) and Other Stem Cell Sources for the Years 2020 &
2027

Table 49: China Current & Future Analysis for Stem Cell Banking
by Service Type - Sample Preservation and Storage, Sample
Analysis, Sample Processing and Sample Collection and
Transportation - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 50: China 7-Year Perspective for Stem Cell Banking by
Service Type - Percentage Breakdown of Value Sales for Sample
Preservation and Storage, Sample Analysis, Sample Processing
and Sample Collection and Transportation for the Years 2020 &
2027

Table 51: China Current & Future Analysis for Stem Cell Banking
by Application - Personalized Banking Applications , Research
Applications and Clinical Applications - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 52: China 7-Year Perspective for Stem Cell Banking by
Application - Percentage Breakdown of Value Sales for
Personalized Banking Applications , Research Applications and
Clinical Applications for the Years 2020 & 2027

EUROPE
Table 53: Europe Current & Future Analysis for Stem Cell
Banking by Geographic Region - France, Germany, Italy, UK and
Rest of Europe Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2020 through 2027 and % CAGR

Table 54: Europe 7-Year Perspective for Stem Cell Banking by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2020 & 2027

Table 55: Europe Current & Future Analysis for Stem Cell
Banking by Source - Placental and Cord Blood Stem Cells,
Adipose Tissue-Derived Stem Cells (ADSCS), Bone Marrow-Derived
Stem Cells (BMSCS), Human Embryo-Derived Stem Cells (HESCS),
Dental Pulp-Derived Stem Cells (DPSCS) and Other Stem Cell
Sources - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 56: Europe 7-Year Perspective for Stem Cell Banking by
Source - Percentage Breakdown of Value Sales for Placental and
Cord Blood Stem Cells, Adipose Tissue-Derived Stem Cells
(ADSCS), Bone Marrow-Derived Stem Cells (BMSCS), Human
Embryo-Derived Stem Cells (HESCS), Dental Pulp-Derived Stem
Cells (DPSCS) and Other Stem Cell Sources for the Years 2020 &
2027

Table 57: Europe Current & Future Analysis for Stem Cell
Banking by Service Type - Sample Preservation and Storage,
Sample Analysis, Sample Processing and Sample Collection and
Transportation - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 58: Europe 7-Year Perspective for Stem Cell Banking by
Service Type - Percentage Breakdown of Value Sales for Sample
Preservation and Storage, Sample Analysis, Sample Processing
and Sample Collection and Transportation for the Years 2020 &
2027

Table 59: Europe Current & Future Analysis for Stem Cell
Banking by Application - Personalized Banking Applications ,
Research Applications and Clinical Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 60: Europe 7-Year Perspective for Stem Cell Banking by
Application - Percentage Breakdown of Value Sales for
Personalized Banking Applications , Research Applications and
Clinical Applications for the Years 2020 & 2027

FRANCE
Table 61: France Current & Future Analysis for Stem Cell
Banking by Source - Placental and Cord Blood Stem Cells,
Adipose Tissue-Derived Stem Cells (ADSCS), Bone Marrow-Derived
Stem Cells (BMSCS), Human Embryo-Derived Stem Cells (HESCS),
Dental Pulp-Derived Stem Cells (DPSCS) and Other Stem Cell
Sources - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 62: France 7-Year Perspective for Stem Cell Banking by
Source - Percentage Breakdown of Value Sales for Placental and
Cord Blood Stem Cells, Adipose Tissue-Derived Stem Cells
(ADSCS), Bone Marrow-Derived Stem Cells (BMSCS), Human
Embryo-Derived Stem Cells (HESCS), Dental Pulp-Derived Stem
Cells (DPSCS) and Other Stem Cell Sources for the Years 2020 &
2027

Table 63: France Current & Future Analysis for Stem Cell
Banking by Service Type - Sample Preservation and Storage,
Sample Analysis, Sample Processing and Sample Collection and
Transportation - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 64: France 7-Year Perspective for Stem Cell Banking by
Service Type - Percentage Breakdown of Value Sales for Sample
Preservation and Storage, Sample Analysis, Sample Processing
and Sample Collection and Transportation for the Years 2020 &
2027

Table 65: France Current & Future Analysis for Stem Cell
Banking by Application - Personalized Banking Applications ,
Research Applications and Clinical Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 66: France 7-Year Perspective for Stem Cell Banking by
Application - Percentage Breakdown of Value Sales for
Personalized Banking Applications , Research Applications and
Clinical Applications for the Years 2020 & 2027

GERMANY
Table 67: Germany Current & Future Analysis for Stem Cell
Banking by Source - Placental and Cord Blood Stem Cells,
Adipose Tissue-Derived Stem Cells (ADSCS), Bone Marrow-Derived
Stem Cells (BMSCS), Human Embryo-Derived Stem Cells (HESCS),
Dental Pulp-Derived Stem Cells (DPSCS) and Other Stem Cell
Sources - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 68: Germany 7-Year Perspective for Stem Cell Banking by
Source - Percentage Breakdown of Value Sales for Placental and
Cord Blood Stem Cells, Adipose Tissue-Derived Stem Cells
(ADSCS), Bone Marrow-Derived Stem Cells (BMSCS), Human
Embryo-Derived Stem Cells (HESCS), Dental Pulp-Derived Stem
Cells (DPSCS) and Other Stem Cell Sources for the Years 2020 &
2027

Table 69: Germany Current & Future Analysis for Stem Cell
Banking by Service Type - Sample Preservation and Storage,
Sample Analysis, Sample Processing and Sample Collection and
Transportation - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 70: Germany 7-Year Perspective for Stem Cell Banking by
Service Type - Percentage Breakdown of Value Sales for Sample
Preservation and Storage, Sample Analysis, Sample Processing
and Sample Collection and Transportation for the Years 2020 &
2027

Table 71: Germany Current & Future Analysis for Stem Cell
Banking by Application - Personalized Banking Applications ,
Research Applications and Clinical Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 72: Germany 7-Year Perspective for Stem Cell Banking by
Application - Percentage Breakdown of Value Sales for
Personalized Banking Applications , Research Applications and
Clinical Applications for the Years 2020 & 2027

ITALY
Table 73: Italy Current & Future Analysis for Stem Cell Banking
by Source - Placental and Cord Blood Stem Cells, Adipose
Tissue-Derived Stem Cells (ADSCS), Bone Marrow-Derived Stem
Cells (BMSCS), Human Embryo-Derived Stem Cells (HESCS), Dental
Pulp-Derived Stem Cells (DPSCS) and Other Stem Cell Sources -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 74: Italy 7-Year Perspective for Stem Cell Banking by
Source - Percentage Breakdown of Value Sales for Placental and
Cord Blood Stem Cells, Adipose Tissue-Derived Stem Cells
(ADSCS), Bone Marrow-Derived Stem Cells (BMSCS), Human
Embryo-Derived Stem Cells (HESCS), Dental Pulp-Derived Stem
Cells (DPSCS) and Other Stem Cell Sources for the Years 2020 &
2027

Table 75: Italy Current & Future Analysis for Stem Cell Banking
by Service Type - Sample Preservation and Storage, Sample
Analysis, Sample Processing and Sample Collection and
Transportation - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 76: Italy 7-Year Perspective for Stem Cell Banking by
Service Type - Percentage Breakdown of Value Sales for Sample
Preservation and Storage, Sample Analysis, Sample Processing
and Sample Collection and Transportation for the Years 2020 &
2027

Table 77: Italy Current & Future Analysis for Stem Cell Banking
by Application - Personalized Banking Applications , Research
Applications and Clinical Applications - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 78: Italy 7-Year Perspective for Stem Cell Banking by
Application - Percentage Breakdown of Value Sales for
Personalized Banking Applications , Research Applications and
Clinical Applications for the Years 2020 & 2027

UNITED KINGDOM
Table 79: UK Current & Future Analysis for Stem Cell Banking by
Source - Placental and Cord Blood Stem Cells, Adipose
Tissue-Derived Stem Cells (ADSCS), Bone Marrow-Derived Stem
Cells (BMSCS), Human Embryo-Derived Stem Cells (HESCS), Dental
Pulp-Derived Stem Cells (DPSCS) and Other Stem Cell Sources -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 80: UK 7-Year Perspective for Stem Cell Banking by Source -
Percentage Breakdown of Value Sales for Placental and Cord
Blood Stem Cells, Adipose Tissue-Derived Stem Cells (ADSCS),
Bone Marrow-Derived Stem Cells (BMSCS), Human Embryo-Derived
Stem Cells (HESCS), Dental Pulp-Derived Stem Cells (DPSCS) and
Other Stem Cell Sources for the Years 2020 & 2027

Table 81: UK Current & Future Analysis for Stem Cell Banking by
Service Type - Sample Preservation and Storage, Sample
Analysis, Sample Processing and Sample Collection and
Transportation - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 82: UK 7-Year Perspective for Stem Cell Banking by
Service Type - Percentage Breakdown of Value Sales for Sample
Preservation and Storage, Sample Analysis, Sample Processing
and Sample Collection and Transportation for the Years 2020 &
2027

Table 83: UK Current & Future Analysis for Stem Cell Banking by
Application - Personalized Banking Applications , Research
Applications and Clinical Applications - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 84: UK 7-Year Perspective for Stem Cell Banking by
Application - Percentage Breakdown of Value Sales for
Personalized Banking Applications , Research Applications and
Clinical Applications for the Years 2020 & 2027

REST OF EUROPE
Table 85: Rest of Europe Current & Future Analysis for Stem
Cell Banking by Source - Placental and Cord Blood Stem Cells,
Adipose Tissue-Derived Stem Cells (ADSCS), Bone Marrow-Derived
Stem Cells (BMSCS), Human Embryo-Derived Stem Cells (HESCS),
Dental Pulp-Derived Stem Cells (DPSCS) and Other Stem Cell
Sources - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 86: Rest of Europe 7-Year Perspective for Stem Cell
Banking by Source - Percentage Breakdown of Value Sales for
Placental and Cord Blood Stem Cells, Adipose Tissue-Derived
Stem Cells (ADSCS), Bone Marrow-Derived Stem Cells (BMSCS),
Human Embryo-Derived Stem Cells (HESCS), Dental Pulp-Derived
Stem Cells (DPSCS) and Other Stem Cell Sources for the Years
2020 & 2027

Table 87: Rest of Europe Current & Future Analysis for Stem
Cell Banking by Service Type - Sample Preservation and Storage,
Sample Analysis, Sample Processing and Sample Collection and
Transportation - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 88: Rest of Europe 7-Year Perspective for Stem Cell
Banking by Service Type - Percentage Breakdown of Value Sales
for Sample Preservation and Storage, Sample Analysis, Sample
Processing and Sample Collection and Transportation for the
Years 2020 & 2027

Table 89: Rest of Europe Current & Future Analysis for Stem
Cell Banking by Application - Personalized Banking Applications
, Research Applications and Clinical Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 90: Rest of Europe 7-Year Perspective for Stem Cell
Banking by Application - Percentage Breakdown of Value Sales
for Personalized Banking Applications , Research Applications
and Clinical Applications for the Years 2020 & 2027

ASIA-PACIFIC
Table 91: Asia-Pacific Current & Future Analysis for Stem Cell
Banking by Source - Placental and Cord Blood Stem Cells,
Adipose Tissue-Derived Stem Cells (ADSCS), Bone Marrow-Derived
Stem Cells (BMSCS), Human Embryo-Derived Stem Cells (HESCS),
Dental Pulp-Derived Stem Cells (DPSCS) and Other Stem Cell
Sources - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 92: Asia-Pacific 7-Year Perspective for Stem Cell Banking
by Source - Percentage Breakdown of Value Sales for Placental
and Cord Blood Stem Cells, Adipose Tissue-Derived Stem Cells
(ADSCS), Bone Marrow-Derived Stem Cells (BMSCS), Human
Embryo-Derived Stem Cells (HESCS), Dental Pulp-Derived Stem
Cells (DPSCS) and Other Stem Cell Sources for the Years 2020 &
2027

Table 93: Asia-Pacific Current & Future Analysis for Stem Cell
Banking by Service Type - Sample Preservation and Storage,
Sample Analysis, Sample Processing and Sample Collection and
Transportation - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 94: Asia-Pacific 7-Year Perspective for Stem Cell Banking
by Service Type - Percentage Breakdown of Value Sales for
Sample Preservation and Storage, Sample Analysis, Sample
Processing and Sample Collection and Transportation for the
Years 2020 & 2027

Table 95: Asia-Pacific Current & Future Analysis for Stem Cell
Banking by Application - Personalized Banking Applications ,
Research Applications and Clinical Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 96: Asia-Pacific 7-Year Perspective for Stem Cell Banking
by Application - Percentage Breakdown of Value Sales for
Personalized Banking Applications , Research Applications and
Clinical Applications for the Years 2020 & 2027

REST OF WORLD
Table 97: Rest of World Current & Future Analysis for Stem Cell

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05799719/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001